News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
128,834 Results
Type
Article (4292)
Company Profile (88)
Press Release (124454)
Section
Business (42083)
Career Advice (208)
Deals (6160)
Drug Delivery (13)
Drug Development (17449)
Employer Resources (18)
FDA (1487)
Job Trends (2780)
News (66237)
Policy (3647)
Tag
2024 BioCapital Digital (2)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (6)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 Biotech Bay Standard (1)
Academia (291)
Adcomms (1)
Allergies (15)
Alliances (11442)
ALS (24)
Alzheimer's disease (309)
Antibody-drug conjugate (ADC) (21)
Approvals (1495)
Artificial intelligence (41)
Autoimmune disease (5)
Automation (3)
Bankruptcy (38)
Best Places to Work (2251)
BIOSECURE Act (13)
Biosimilars (4)
Biotechnology (85)
Bladder cancer (17)
Brain cancer (6)
Breast cancer (60)
Cancer (463)
Cardiovascular disease (14)
Career advice (196)
Career pathing (4)
CAR-T (51)
Cell therapy (154)
Cervical cancer (4)
Clinical research (14016)
Collaboration (224)
Compensation (88)
Complete response letters (2)
COVID-19 (428)
CRISPR (5)
C-suite (86)
Cystic fibrosis (25)
Data (490)
Depression (6)
Diabetes (42)
Diagnostics (690)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (40)
Drug pricing (5)
Drug shortages (2)
Duchenne muscular dystrophy (17)
Earnings (12351)
Editorial (4)
Employer resources (18)
Events (24464)
Executive appointments (222)
FDA (1687)
Featured Employer (13)
Frontotemporal dementia (5)
Funding (186)
Gene editing (16)
Generative AI (4)
Gene therapy (72)
GLP-1 (104)
Government (340)
Guidances (8)
Healthcare (1528)
Huntington's disease (6)
IgA nephropathy (4)
Immunology and inflammation (21)
Indications (8)
Infectious disease (452)
Inflammatory bowel disease (47)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (26)
Interviews (17)
IPO (2925)
IRA (4)
Job creations (667)
Job search strategy (184)
Kidney cancer (1)
Labor market (5)
Layoffs (36)
Legal (636)
Liver cancer (12)
Lung cancer (35)
Lymphoma (41)
Management (4)
Manufacturing (71)
MASH (8)
Medical device (401)
Medtech (401)
Mergers & acquisitions (3401)
Metabolic disorders (98)
Multiple sclerosis (18)
NASH (1)
Neurodegenerative disease (12)
Neuropsychiatric disorders (3)
Neuroscience (414)
NextGen: Class of 2025 (858)
Non-profit (273)
Northern California (710)
Now hiring (4)
Obesity (51)
Opinion (37)
Ovarian cancer (24)
Pain (19)
Pancreatic cancer (17)
Parkinson's disease (29)
Partnered (3)
Patents (47)
Patient recruitment (23)
Peanut (11)
People (16334)
Pharmaceutical (8)
Phase I (5574)
Phase II (6687)
Phase III (3427)
Pipeline (227)
Podcasts (2)
Policy (23)
Postmarket research (209)
Preclinical (2373)
Press Release (51)
Prostate cancer (17)
Psychedelics (2)
Radiopharmaceuticals (44)
Rare diseases (61)
Real estate (1442)
Recruiting (10)
Regulatory (2933)
Reports (12)
Research institute (299)
Resumes & cover letters (20)
RSV (4)
Schizophrenia (12)
Series A (33)
Series B (24)
Service/supplier (2)
Sickle cell disease (10)
Southern California (636)
Special edition (1)
Sponsored (4)
Startups (983)
State (1)
Stomach cancer (2)
Supply chain (12)
The Weekly (2)
United States (5390)
Vaccines (68)
Venture capitalists (7)
Webinars (6)
Weight loss (19)
Women's health (4)
Worklife (2)
Date
Today (32)
Last 7 days (160)
Last 30 days (746)
Last 365 days (8945)
2025 (1614)
2024 (9147)
2023 (9887)
2022 (12001)
2021 (12651)
2020 (9855)
2019 (6682)
2018 (5281)
2017 (6081)
2016 (5593)
2015 (6446)
2014 (4927)
2013 (4070)
2012 (4424)
2011 (4877)
2010 (4520)
Location
Africa (139)
Alabama (26)
Alaska (1)
Arizona (24)
Arkansas (2)
Asia (8439)
Australia (1987)
California (1620)
Canada (492)
China (93)
Colorado (28)
Connecticut (60)
Delaware (22)
Europe (18344)
Florida (145)
Georgia (21)
Idaho (10)
Illinois (115)
India (3)
Indiana (88)
Iowa (1)
Japan (28)
Kansas (11)
Kentucky (2)
Louisiana (1)
Maine (2)
Maryland (189)
Massachusetts (1181)
Michigan (63)
Minnesota (82)
Missouri (6)
Montana (8)
Nebraska (2)
Nevada (4)
New Hampshire (4)
New Jersey (370)
New Mexico (6)
New York (394)
North Carolina (240)
North Dakota (3)
Northern California (710)
Ohio (33)
Oklahoma (4)
Oregon (3)
Pennsylvania (334)
Puerto Rico (2)
Rhode Island (4)
South America (199)
South Carolina (1)
Southern California (636)
Tennessee (14)
Texas (181)
Utah (16)
Virginia (10)
Washington D.C. (7)
Washington State (293)
Wisconsin (5)
128,834 Results for "puma biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference
March 5, 2025
·
2 min read
Press Releases
Puma Biotechnology to Present at Barclays 27th Annual Global Healthcare Conference
March 5, 2025
·
2 min read
Press Releases
Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results
February 27, 2025
·
19 min read
Press Releases
Puma Biotechnology to Present at TD Cowen’s 45th Annual Health Care Conference
February 26, 2025
·
2 min read
Press Releases
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - March 5, 2025
March 5, 2025
·
2 min read
Press Releases
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results
February 14, 2025
·
2 min read
Press Releases
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - February 5, 2025
February 5, 2025
·
2 min read
Press Releases
Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation
December 23, 2024
·
8 min read
Biotech Beach
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - June 07, 2024
Puma Biotechnology, Inc., a biopharmaceutical company, announced that on June 6, 2024, the Compensation Committee of Puma’s Board of Directors approved the grant of an inducement restricted stock unit award covering 3,500 shares of Puma common stock to one new non-executive employee.
June 7, 2024
·
2 min read
Business
Puma Biotechnology Reports First Quarter 2024 Financial Results
Puma Biotechnology, Inc., a biopharmaceutical company, announced financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
15 min read
1 of 12,884
Next
